This 2018 publication from the National Sheriff’s Association and the National Commission on Correctional Health Care provides guidance on how to create and manage a medication assisted treatment program
This 2 minute video accompanies the National Academies of Science, Engineering and Medicine’s report Medications for Opioid Use Disorder Save Lives.
This program evaluation looks at California’s implementation of a hub-and-spoke treatment system for opioid use disorder (OUD) during the program’s first year (August 2017 to July 2018).
The Yale School of Medicine’s website contains comprehensive resources for providers interested in setting up a program to initiate buprenorphine treatment for individuals with opioid use disorder (OUD) seen in the emergency department (ED).
In 2017 the Camden Coalition of Healthcare Providers began a pilot in partnership with local addiction treatment providers and UnitedHealthCare to see if removing prior authorization requirements for buprenorphine would reduce barriers to treatment and improve patient and system outcomes.
State officials participating in the Medicaid Evidence-based Decisions Project requested this rapid evidence review on the role of inpatient or residential detoxification for the treatment of opioid use disorder (OUD). As this 2-page document states, research is clear and addiction experts agree that detoxification alone is not a stand-alone treatment for OUD, but is merely the first step in a providing an individualized treatment plan which may include medication assisted treatment.
This 2018 report from the Centers for Disease Control describes evidence-based strategies to prevent opioid overdose based on a review of the published evidence and consultation with subject matter experts. The report describes 10 strategies that could be implemented by public health officials, law enforcement, local organizations or other community leaders.
The comprehensive Mother & Baby Substance Exposure Toolkit was created by the California Perinatal Quality Care Collaborative, the California Maternal Quality Care Collaborative, and HMA Institute on Addiction. This toolkit provides information on treating mothers and newborns from the prenatal period through hospital discharge with a focus on opioid-related conditions.
A 2011 report about how Kentucky’s drug courts access and use data from the state’s prescription drug monitoring program (PDMP) from the PDMP Center of Excellence at Brandeis University.
This briefing paper from the National Judicial Opioid Task Force provides an overview of parent partner programs, where parents facing child welfare or dependency proceedings are paired with a peer adviser who helps them understand and navigate the process. Parent partner programs in Washington, Iowa,